Thursday observed a rise in the US dollar against the Japanese yen, while it slipped down against the euro.
The US dollar rose from ¥83.26 to ¥83.64 against the yen. The losses to yen are supposed to be due to the Federal Reserve's decision to expand monetary stimulus. It said that it would be buying additional ling-maturity securities worth $45 billion.
Further, the Federal Reserve asserted that it would also maintain the low interest rates until the unemployment rates come down to less than 6.5% and inflation sees some acceleration. "Japanese exporters put currency hedges in place around ¥83. If these firms believe the pair will have a sustained move above ¥83, then you may see a number of them unwind", said Stan Shamu, a strategist at IG markets.
Euro rose from $1.3070 to $1.3081 on late Wednesday. Swiss Bank's monetary policy is due later Thursday, it was trapped in tight range. British pound went down from $1.6146 to $1.6141 while Australian dollar rose from $1.0544 to $1.0552. The New Zealand dollar rose from 83.92 U. S. cents to 83.98 U. S. cents.
The Federal Open Market Committee is expected to announce $45 billion in monthly Treasury, which if bought will raise the balance sheet up to $4 trillion.
In a recent announcement, Sega has revealed that its Steam catalog of classic Genesis and Mega Drive games is being updated with a new 3D interface --- the Sega Mega Drive Classics Hub.
Announcing the Classics Hub, Sega said that the new...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Wednesday, European competition authorities unveiled...
The button white mushroom edited using CRISPR has...
In a Tuesday announcement, Supergiant Games studio’s...
According to a CNN report, the Federal Investigation...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).